ID
12806
Description
Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01523782
Link
https://clinicaltrials.gov/show/NCT01523782
Keywords
Versions (1)
- 12/21/15 12/21/15 -
Uploaded on
December 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT01523782
Eligibility Acute Lymphoblastic Leukemia NCT01523782
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
all t(9;22) and/or bcr-abl positive
Data type
boolean
Alias
- UMLS CUI [1]
- C0279592
- UMLS CUI [2]
- C2861580
Description
general state incompatible with chemotherapy treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C1298650
- UMLS CUI [2]
- C0392920
Description
contraindication
Data type
boolean
Alias
- UMLS CUI [1]
- C1301624
Description
malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
communicable disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
l-asparaginase
Data type
boolean
Alias
- UMLS CUI [1]
- C0003993
Description
transfusional incident
Data type
boolean
Alias
- UMLS CUI [1]
- C0161840
Description
anti-erythrocyte antibodies
Data type
boolean
Alias
- UMLS CUI [1]
- C1112584
Description
study subject participation status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT01523782
- StudyEvent: Eligibility
C2861580 (UMLS CUI [2])
C0392920 (UMLS CUI [2])